As with all solutions for intravenous infusion, febrile reactions, injection site infections, venous thrombosis or phlebitis, and extravasation may occur
GLP-1 receptors sit throughout the body, in the brain, pancreas, heart, and blood vessels, and the drugs appear to reduce inflammation and the organ-damaging fat that drives much metabolic harm
Breakthrough spotting between periods shows up occasionally too, and while it's usually not dangerous, it's disruptive and honestly kind of annoying when you're not expecting it
This approach prevents physiologic tolerance, maintains effectiveness, and reduces the risk of diminishing results over time